|
Re: Give us just one or two NR’s - money, partners & timeframe
|
3
|
Resverlogix Corp.
|
Apr 14, 2021 06:30PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
5
|
Resverlogix Corp.
|
Apr 14, 2021 11:11AM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 21, 2017 02:54PM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 22, 2017 04:44PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
1
|
Resverlogix Corp.
|
Apr 20, 2016 01:09PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
2
|
Resverlogix Corp.
|
Apr 20, 2016 09:36AM
|
|
Re: Funds
|
4
|
Resverlogix Corp.
|
Feb 19, 2023 10:57AM
|
|
Re: Funding
|
1
|
Resverlogix Corp.
|
Jun 23, 2017 02:09PM
|
|
Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 02:52PM
|
|
Re: From the floor at AGM
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 12:22PM
|
|
Re: from Sarah yesterday afternoon...
|
7
|
Resverlogix Corp.
|
Jan 12, 2022 11:18AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
2
|
Resverlogix Corp.
|
May 26, 2017 10:41AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
|
Resverlogix Corp.
|
May 26, 2017 01:50PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
|
Resverlogix Corp.
|
May 26, 2017 03:53PM
|
|
Re: Form 45-106F1 Report of Exempt Distribution Dec 13, 2021
|
4
|
Resverlogix Corp.
|
Dec 14, 2021 09:34AM
|
|
Re: For those complaining about the money DM makes....
|
3
|
Resverlogix Corp.
|
May 07, 2016 11:54AM
|
|
Re: First Dosing v "Actively Recruiting" ?
|
4
|
Resverlogix Corp.
|
Nov 12, 2021 11:33AM
|
|
Re: First Dosing v "Actively Recruiting" ?
|
5
|
Resverlogix Corp.
|
Nov 11, 2021 11:18AM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
4
|
Resverlogix Corp.
|
Aug 13, 2022 10:28AM
|
|
Re: Financials/MD&A -SEDAR June 30/22
|
3
|
Resverlogix Corp.
|
Aug 13, 2022 12:37PM
|
